Clinical trials
Endocrine Gland Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Celgene | 1 |
| NantCell, Inc. | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine Gland Neoplasms | 6 |
| Neoplasms | 6 |
| Endocrine System Diseases | 5 |
| Neoplasms by Site | 5 |
| Adenocarcinoma | 3 |
| Bronchial Neoplasms | 3 |
| Carcinoma, Bronchogenic | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colonic Neoplasms | 3 |
| Digestive System Neoplasms | 3 |
Trials
Showing 76 to 6 of 6. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.